These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20055104)

  • 1. Challenges and potential for RNA nanoparticles (RNPs).
    Davis D; Akhtar U; Keaster B; Grozinger K; Washington L; Kelsey S; Sarkar A; DeLong RK
    J Biomed Nanotechnol; 2009 Feb; 5(1):36-44. PubMed ID: 20055104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and performance of nucleic acid nanoparticles combined with protamine and gold.
    DeLong RK; Akhtar U; Sallee M; Parker B; Barber S; Zhang J; Craig M; Garrad R; Hickey AJ; Engstrom E
    Biomaterials; 2009 Nov; 30(32):6451-9. PubMed ID: 19726081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle therapeutics: a personal perspective.
    McNeil SE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress of researches on drug-loaded nanoparticles].
    Zhao J; Sheng Y; Shan X; Zhang X; Yuan Y; Liu C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):220-3. PubMed ID: 18435295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines.
    Nicolas J; Couvreur P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(1):111-127. PubMed ID: 20049783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for respiratory diseases.
    Swai H; Semete B; Kalombo L; Chelule P; Kisich K; Sievers B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):255-63. PubMed ID: 20049795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized gold nanoparticles for drug delivery.
    Han G; Ghosh P; Rotello VM
    Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine: nanocarriers shape up for long life.
    Nishiyama N
    Nat Nanotechnol; 2007 Apr; 2(4):203-4. PubMed ID: 18654260
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid nanomedicines for anticancer drug therapy.
    Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Prieto MJ
    J Biomed Nanotechnol; 2009 Aug; 5(4):323-43. PubMed ID: 20055079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Insight into Nanomedicinal Approaches to Combat Viral Zoonoses.
    Minakshi P; Ghosh M; Kumar R; Brar B; Lambe UP; Banerjee S; Ranjan K; Kumar B; Goel P; Malik YS; Prasad G
    Curr Top Med Chem; 2020; 20(11):915-962. PubMed ID: 32209041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
    Yuan H; Zhang W; Du YZ; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput screening assay for the functional delivery of splice-switching oligonucleotides in human melanoma cells.
    Dean JM; DeLong RK
    Methods Mol Biol; 2015; 1297():187-96. PubMed ID: 25896004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted nanoparticle-based drug delivery and diagnosis.
    Emerich DF; Thanos CG
    J Drug Target; 2007 Apr; 15(3):163-83. PubMed ID: 17454354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.